Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More General business news Stock market bloodbath: 20 ASX shares crash up to 34% as global volatility and sector turmoil hit hard What triggered today’s biggest ASX stock losses? On April 22, 2025, the Australian stock market witnessed a broad-based… byPallavi MadhirajuApril 22, 2025